AQBIO LIMITED
Significant control: Professor Anthony Cass (25–50%), David Sarphie (25–50%) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aqbio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Aqbio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
AQBIO LIMITED is an active private limited company (company number 11231380) incorporated on 1 March 2018, registered in Richmond. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 March 2025, showing net assets of £20 and cash of £20, with 0 employees on average. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
Ownership and control
- Professor Anthony Cass
- owns 25–50% of shares
- owns 25–50% of shares
- holds 25–50% of voting rights
- holds 25–50% of voting rights
- Dr David Sarphie
- owns 25–50% of shares
- owns 25–50% of shares
- holds 25–50% of voting rights
- holds 25–50% of voting rights
- Mr Gabriel Aeppli
- owns 25–50% of shares
- holds 25–50% of voting rights
- Gabriel Aeppli
- owns 25–50% of shares
- owns 25–50% of shares
- holds 25–50% of voting rights
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 1 March 20188 yrs ago
- Next accounts due
- 31 December 2026in 65 days
- Confirmation statement due
- 15 March 2027in 139 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £20 | £20 | — | — | — | — | 0 |
| 31 March 2024 | £20 | £20 | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £20 at 31 March 2025
- Incorporated five or more years agoIncorporated 1 March 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 139 days
- Next accounts duein 65 days
- Accounts period endNet assets £20 · dormant accounts
- Accounts period endNet assets £20 · dormant accounts
- Incorporated
Similar companies in Greater London
- ADVANCED CELL TECHNOLOGIES LTDBarnet · inc. Feb 2018
- GENEALFA LIMITEDCroydon · inc. Mar 2018
- ETHERICA LTDCroydon · inc. Jan 2018
- DR GARY MOORE CONSULTING LIMITEDBexley · inc. Jan 2018
- SMCGSTAT LTDUxbridge · inc. Apr 2018
- NEOHAIR LTDWest Drayton · inc. Apr 2018
All companies incorporated on 1 March 2018 · in Mar 2018.
Reminders for AQBIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.